Abstract
Feasibility Study of the HighLife 28mm Trans-septal Trans-catheter Mitral Valve in Patients With Moderate-severe or Severe Mitral Regurgitation and at High Surgical Risk
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have